June 2025, An international multi-centre PROspective study, including PROMS of PARTial BREast ReCONstruction with chest wall perforator flap
A study by the Breast Consortium (BreCon) – NCT06728527
Brief Description
A prospective multicenter cohort study to evaluate the clinical and patient-reported outcomes following breast-conserving surgery and partial breast reconstruction with chest wall perforator flap.
Protocol:
https://www.eubreast.org/wp-content/uploads/2025/06/PartBreCon-PRO-protocol-Jun25-v.5.1.pdf
Contact information:
Chief Investigator: Dr Amit Agrawal, Cambridge, UK Study contact: partbrecon.pros@gmail.com
Inclusion/Exclusion Criteria
Inclusion criteria: – Patients undergoing partial breast reconstruction using CWPF for primary breast cancer
– Delayed correction of breast deformity following previous BCS
– Each surgeon is to have performed a minimum of 10 CWPFs
– Each center anticipates completing a minimum of 10/year
Exclusion criteria:
– Patients undergoing volume displacement BCS
– Patients undergoing mastectomy +/- immediate breast reconstruction
Support Letter:
Any new centers should please send this support letter back to partbrecon.pros@gmail.com after local approval.
ClinicalTrials.gov Identifier:
https://clinicaltrials.gov/study/NCT06728527?term=nct06728527&rank=1
Deadline
The project has recently been granted a two-year extension from June 2026 to June 2028.
